Bausch Health Companies Inc (NYSE:BHC)
| 31.00 Delayed Data As of Dec 13 |  -0.89 / -2.79%Today’s Change | 17.20 Today|||52-Week Range 31.97 | +67.84% Year-to-Date |
Latest BHC News | Press Releases
| 4 FDA Dates Biotech Investors Should Circle in December Dec 07 / MotleyFool.com - Paid Partner Content | Why Bausch Health Companies Stock Popped in November Dec 04 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 31.89 |
| Today’s open | 31.85 |
| Day’s range | 30.94 - 31.97 |
| Volume | 4,951,002 |
| Average volume (3 months) | 3,732,696 |
| Market cap | $10.9B |
Data as of 6:30pm ET, 12/13/2019
Growth & Valuation
| Earnings growth (last year) | -272.12% |
| Earnings growth (this year) | +8.57% |
| Earnings growth (next 5 years) | +6.30% |
| Revenue growth (last year) | -3.94% |
| P/E ratio | NM |
| Price/Sales | 0.77 |
| Price/Book | 3.97 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MYLMylan NV | -0.54 | -2.74% |
| GLPGGalapagos NV | -6.33 | -2.94% |
| ALNYAlnylam Pharmaceutic... | -2.87 | -2.38% |
| IONSIonis Pharmaceutical... | +0.83 | +1.33% |
Data as of 4:00pm ET, 12/13/2019
Financials
| Next reporting date | March 2, 2020 |
| EPS forecast (this quarter) | $1.14 |
| Annual revenue (last year) | $8.4B |
| Annual profit (last year) | -$4.1B |
| Net profit margin | -49.50% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Laval, Quă©bec |
Forecasts
